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https://doi.org/10.1016/j.celrep.2020.107664SUMMARYCullin-RING ligases (CRLs) control key cellular processes by promoting ubiquitylation of a multitude of sol-
uble cytosolic and nuclear proteins. Subsets of CRL complexes are recruited and activated locally at cellular
membranes; however, few CRL functions and substrates at these distinct cellular compartments are known.
Here, we use a proteomic screen to identify proteins that are ubiquitylated at cellular membranes and found
that Lunapark, an endoplasmic reticulum (ER)-shaping protein localized to ER three-way junctions, is ubiq-
uitylated by the CRL3KLHL12 ubiquitin ligase. We demonstrate that Lunapark interacts withmechanistic target
of rapamycin complex-1 (mTORC1), a central cellular regulator that coordinates growth andmetabolismwith
environmental conditions. We show that mTORC1 binds Lunapark specifically at three-way junctions, and
lysosomes, where mTORC1 is activated, make contact with three-way junctions where Lunapark resides. In-
hibition of Lunapark ubiquitylation results in neurodevelopmental defects indicating that KLHL12-dependent
ubiquitylation of Lunapark is required for normal growth and development.INTRODUCTION
Cullin-RING ligases (CRLs), the largest class of modular E3 ubiq-
uitin ligases, control essential cellular processes by targeting
protein substrates for ubiquitylation (Petroski and Deshaies,
2005). CRLs are composed of a cullin scaffold, a RING-finger
protein (RBX1 or RBX2), an adaptor protein, and one of many
substrate-receptor subunits. CRL activity is promoted by the
reversible conjugation of the ubiquitin-like protein NEDD8 to
the cullin subunit (Scott et al., 2014). Like ubiquitylation, neddy-
lation of substrates is achieved by an enzymatic cascade.
NEDD8 is first activated by specific E1 and E2 enzymes and
then conjugated by E3 enzymes to a lysine residue of the cullin
target through an isopeptide bond (Lydeard et al., 2013). A
‘‘dual E3’’ mechanism has been proposed for cullin neddylation,
where one E3, RBX1, works as a typical E3 by recruiting both the
cullin substrate and the E2-NEDD8 intermediate triggering
NEDD8 ligation, and a second E3, termed co-E3, facilitates
this process (Lydeard et al., 2013; Scott et al., 2010, 2011).
This auxiliary scaffold-like co-E3 function is played by defective
in Cul neddylation protein (DCN) in yeast and DCNL1 to DCNL5
in humans (DCN-like proteins). DCN and DCN-like proteinsThis is an open access article undinteract with the cullin subunit nearby its neddylation site as
well as the acetylated N terminus of the E2 enzyme (UBC12)
structurally constraining the RBX1-UBC12-NEDD8 complex to
orientations that increase the kinetic efficiency of the NEDD8
conjugation to the right lysine residue (Kurz et al., 2005, 2008;
Monda et al., 2013). Notably, one DCNL protein, DCNL3, has
been shown to be localized to cellular membranes through an
N-terminal lipid-modified motif (Keuss et al., 2016; Meyer-Schal-
ler et al., 2009). Membrane-bound DCNL3 recruits CRLs to
membranes where it contributes to their neddylation (Keuss
et al., 2016; Meyer-Schaller et al., 2009).
The endoplasmic reticulum (ER), the largest membrane-bound
organelle in eukaryotes, is a contiguous structure that extends
from the nuclear envelope to the plasma membrane (Chen
et al., 2013; Friedman and Voeltz, 2011; Phillips and Voeltz,
2016). The ER is composed of two main structural units, namely
flat cisternal sheets and reticulated tubules. Whereas the
cisternae are connected to the nuclear envelope and are localized
mostly to the perinuclear region, the tubules form a polygonal
network that extends throughout the cytoplasm. This polygonal
array is highly dynamic as it undergoes rapid and constant reor-
ganizations such as tubule extension and retraction, branching,Cell Reports 31, 107664, May 19, 2020 ª 2020 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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of the ER tubule network are three-way junctions, mobile ER
intersections generated by the fusion of one ER tubule tip
with the side of another tubule. Lunapark, a recently identified
factor implicated in ER morphology, is an evolutionarily
conserved transmembrane protein that specifically localizes to
ER three-way junctions. Although Lunapark is thought to stabilize
these junctions and inhibit ring closure (Chen et al., 2012, 2015;
Wang et al., 2016), its function and regulation are still poorly
understood.
Mechanistic target of rapamycin complex 1 (mTORC1) is an
evolutionarily conserved serine-threonine protein kinase complex
that controls metabolic processes underlying the growth of cells,
tissues, and organs (Saxton and Sabatini, 2017). In response to
favorable internal and external cues,mTORC1 is activated to pro-
mote anabolic processes such as protein, lipid, and nucleotide
synthesis, and inhibit catabolic processes like autophagy. Two in-
dependent conditions have to be achieved to activate mTORC1.
First, mTORC1 has to transiently translocate to the lysosomal
membrane in response to amino acids, a process promoted by
the direct binding of activated Rag GTPases to Raptor, which
forms a stoichiometric complex with mTOR and associates with
the mTOR substrates eukaryotic initiation factor 4E-binding pro-
tein-1 and ribosomal protein S6 kinase (Kim et al., 2008;Manifava
et al., 2016; Sancak et al., 2008; Sekiguchi et al., 2001). Second,
lysosome-localized mTORC1 has to interact with Ras homolog
enriched in brain (Rheb), a small GTPase that is activated in
response to growth factors. Thus, the lysosome represents the
cellular hubwhere theaminoacid- and growth factor-sensingma-
chineries intersect to activate mTORC1.
In this study, we have carried out a screen aimed at the iden-
tification of CRL substrates that are specifically ubiquitylated at
cellular membranes. We specifically focused on CRL3 com-
plexes, members of a subclass of Cullin-RING ubiquitin ligases
composed of the cullin scaffold Cul3 and a broad-complex,
tramtrack, and bric-a-brac (BTB) protein as a substrate recep-
tor subunit. Using this screen, we identified the ER-shaping
protein Lunapark as a substrate of CRL3KLHL12, a ubiquitin
ligase complex containing the BTB protein kelch like family
member 12 (KLHL12) as substrate receptor (Angers et al.,
2006; Jin et al., 2012; Rondou et al., 2008). To investigate the
biological function of Lunapark ubiquitylation, we have ex-
pressed a ubiquitylation-resistant Lunapark mutant in cultured
cells as well as in zebrafish embryos. The results of these
studies are herein presented.
RESULTS
A Proteomic Approach for the Identification of CRL
Substrates that Are Ubiquitylated at Cellular
Membranes
To systematically identify targets of the CRL3 ubiquitin ligase
complexes that are ubiquitylated locally at cellular membranes,
we performed affinity-purification and mass spectrometry anal-
ysis of CUL3 variants bearing, at their N termini, the lipid-modi-
fiedmotif (N11) of DCNL3, a co-E3 that contributes to the neddy-
lation of CRL complexes at membranes (Keuss et al., 2016; Kurz
et al., 2005, 2008; Meyer-Schaller et al., 2009; Monda et al.,2 Cell Reports 31, 107664, May 19, 20202013; Scott et al., 2010, 2011). A schematic representation of
the experimental design is shown in Figure 1A. The presence
of the lipid-modified motif of DCNL3 at the N terminus of CUL3
is sufficient to stably recruit CUL3 to the plasma membrane
and endomembranes (Figures 1B and S1) (Meyer-Schaller
et al., 2009). To increase the stability of the CUL3-BTB protein-
substrate complexes, the lipid-modified motif (N11) of DCNL3
was fused to two CUL3 mutants encoding the first 199 or 225
N-terminal amino acid residues (CUL3-N199 and CUL3-N225,
respectively), which are unable to interact with RBX1. We ex-
pressed FLAG-tagged N11-CUL3-N199 or N11-CUL3-N225 as
well as FLAG-tagged CUL3-N199 or CUL3-N225 without the
lipid-modified motif (N11) in HEK293T cells and purified CUL3
immunoprecipitates, which were then analyzed by mass spec-
trometry. In addition to 51 BTB proteins and the RING-finger pro-
tein RBX1 (Figure 1C), which are known to directly bind CUL3
within the CRL3 complex, and various components of the CSN
complex that play a regulatory role (not shown), we recovered
numerous CRL3 candidate substrates. At least three of them
(i.e., GBB1, GBB2, and ACLY) are known CRL3 targets (Bertocci
et al., 2017; Brockmann et al., 2017; Zhang et al., 2016). Among
the top 21 hits that were enriched in the pull-down of membrane-
bound CUL3 (Figure 1D), 19 proteins are (1) described multi-
pass or single-pass membrane proteins, (2) reported to contain
putative transmembrane domains, or (3) found associated to
the plasma membrane or membranes of various cellular organ-
elles (The UniProt Consortium, 2017).
Lunapark Is Ubiquitylated by the CRL3KLHL12 Ubiquitin
Ligase Complex
Among the proteins found enriched in the affinity purification of
membrane-bound CUL3 mutants (N11-CUL3-N199 or N11-
CUL3-N225), we recovered Lunapark (Figure 1D; Tables S1
and S2), an evolutionarily conserved integral membrane protein
involved in network formation of the ER (Chen et al., 2012, 2015;
Goyal and Blackstone, 2013; Moriya et al., 2013; Shemesh et al.,
2014; Wang et al., 2016). The interaction between N11-CUL3-
N225 and endogenous Lunapark was confirmed by immunopre-
cipitation followed by immunoblotting (Figure 2A).
If Lunapark is a substrate of a CRL3 ubiquitin ligase, a specific
BTB protein is expected to bind it and recruit it to CUL3 and the
rest of the CRL3 complex. To identify the BTB protein that inter-
acts with Lunapark, we immunopurified FLAG-tagged Lunapark
fromHEK293T cells. Mass spectrometry analysis of immunopre-
cipitated Lunapark identified the BTB protein KLHL12 as well as
the CRL subunits RBX1 and CUL3 (Figure 2B) (Angers et al.,
2006; Jin et al., 2012; Rondou et al., 2008). KLHL12 was the
only BTB protein (out of the 169BTBproteins encoded by the hu-
man genome) recovered in the affinity purification of FLAG-
tagged Lunapark. The KLHL12-Lunapark interaction was
confirmed by immunoprecipitation followed by immunoblotting
(Figure 2C). Other BTB proteins, namely KLHL18, KCTD11,
and SPOP/BTBD32, did not coimmunoprecipitate with endoge-
nous Lunapark (Figure 2D). A complex with endogenous
Lunapark and KLHL12 was also observed (Figure 2E). These re-
sults suggest that the CRL3KLHL12 ubiquitin ligase mediates
Lunapark ubiquitylation. To test this hypothesis, we examined
whether ectopic expression of KLHL12 stimulates Lunapark
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Figure 1. AP-MS-Based Screen to Identify CRL Substrates at Cellular Membranes
(A) Schematic representation of the experimental design aimed at identifying membrane associated CUL3 substrates.
(B) The indicated FLAG-tagged CUL3-N199 (top) and CUL3-N225 mutants (bottom) were expressed in HeLa cells. Cells were fixed and analyzed by immuno-
fluorescence with an anti-FLAG antibody. DNA was stained with DAPI (blue). Bar indicates 20 mm.
(C and D) Graphical summary of CUL3 interactors, BTB proteins and RBX1 (C) and candidate substrates (D) that were recovered in the cytosolic/nuclear CUL3
pull-down (blue) or in the membrane-bound CUL3 pull-down (green). UniProt entry names are indicated on the X axes. Normalized spectral abundance factors
(NSAFs) are shown on the Y axes.
See also Figure S1 and Tables S1 and S2.
Cell Reports 31, 107664, May 19, 2020 3
Article
ll
OPEN ACCESS
A B E F
HGDC
Figure 2. Lunapark Is a Substrate of the CRL3KLHL12 Ubiquitin Ligase
(A) HEK293T cells were transfected with an empty vector (EV) or the indicated FLAG-tagged CUL3mutants. Whole-cell extracts (WCE) were immunoprecipitated
(IP) with anti-FLAG resin and immunocomplexes were probed with antibodies to the indicated proteins. In all panels, black asterisks mark the FLAG-tagged
proteins both in the IP and in the WCE.
(B) FLAG-tagged Lunapark was expressed in HEK293T cells. Cells were lysed and WCEs were subjected to immunoprecipitation using FLAG beads. Lunapark
immunoprecipitates were then analyzed by mass spectrometry. The number of unique peptides identified by mass spectrometry in Lunapark and control im-
munopurifications is shown.
(C) HEK293T cells, transfected with FLAG-tagged Lunapark, the transmembrane protein TMEM47, and the membrane-bound N11-CUL3-N225 mutant, were
lysed. WCE were immunoprecipitated (IP) with anti-FLAG resin and analyzed by immunoblotting.
(D) HEK293T cells, transfected with an EV or several FLAG-tagged BTB proteins, were lysed. WCE were used for FLAG immunoprecipitation and analyzed by
immunoblotting. Note that the expressed CUL3 mutant does not contain the N-terminal lipid-modified motif and thus, as expected, does not interact with
Lunapark.
(E) WCE from HEK293T cells were immunoprecipitated with an anti-Lunapark antibody. Lunapark immunocomplexes were then probed with antibodies to the
indicated proteins. The red asterisk marks the IgG bands.
(F) HEK293T cells were transfected with HA-tagged Lunapark and MYC-tagged ubiquitin (wild-type [WT] or lysine-less [K-less]), with or without FLAG-tagged
KLHL12. WCE were prepared in denaturing buffer and immunoprecipitated with an anti-MYC antibody. Immunoprecipitates were then immunoblotted to detect
ubiquitylated Lunapark.
(G) Schematic representation of WT KLHL12 and two KLHL12 deletion mutants (top). HEK293T cells, transfected with an empty vector (EV), FLAG-tagged WT
KLHL12 or the indicated KLHL12 mutants, were lysed. WCE were used for FLAG immunoprecipitations and probed for Lunapark binding by immunoblotting
(bottom).
(H) As in (F), except that the KLHL12-DKelch4-6 mutant was also expressed.
See also Figure S2.
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ubiquitylation is increased upon expression of KLHL12.
The BTB-Kelch proteins that form CRL3 ubiquitin ligase com-
plexes contain an N-terminal BTB domain, which mediates their
interaction with CUL3, and C-terminal Kelch repeats, which are
required for substrate binding (Pintard et al., 2004). To test
whether the Kelch repeats of KLHL12 are required for its interac-
tion with Lunapark, we generated two KLHL12 mutants lacking
either the first three or the last three Kelch repeats and assessed
their ability to coimmunoprecipitate with endogenous Lunapark.
As shown in Figure 2G, the two KLHL12-DKelch mutants do not
interact with Lunapark further supporting a substrate-like inter-
action. Accordingly, the KLHL12-DKelch mutants are not able
to stimulate Lunapark ubiquitylation in cells (Figures 2H and4 Cell Reports 31, 107664, May 19, 2020S2A). Taken together, these results suggest that Lunapark is a
substrate of the CRL3KLHL12 ubiquitin ligase complex.
We then examined whether KLHL12-mediated ubiquitylation
regulates Lunapark abundance. Treatment of cells with the
NEDD8-activating enzyme inhibitor MLN4924, which blocks
cullin neddylation and thus CRL activity, does not lead to Luna-
park accumulation, but results in the accumulation of the CRL1
substrate b-catenin (Figure S2B). Likewise, proteasome inhibi-
tion by MG132 treatment does not have any effect on Lunapark
abundance or turnover, whereas it leads to stabilization of the
CRL1 substrates b-catenin and p27 (Figures S2B and S2C).
Modulation of KLHL12 expression by RNA interference (Fig-
ure S2D) or overexpression (Figure S2E) does not result in any
detectable change in the abundance of Lunapark. During
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(Wang et al., 2016). Because it has been suggested that phos-
phorylated Lunapark might be targeted for degradation in
mitosis, we tested the effect of proteasome or CRL inhibition
on the abundance of phosphorylated Lunapark. As shown in Fig-
ure S2F, Lunapark protein levels are not affected by either
MG132 or MLN4924 treatment of mitotic cells. Taken together,
these results demonstrate that Lunapark is ubiquitylated by the
CRL3KLHL12 ubiquitin ligase, and the CRL3KLHL12-dependent
ubiquitylation of Lunapark does not lead to its proteasomal
degradation.
Analysis of the Minimal KLHL12-Binding Domain of
Lunapark
Lunapark contains two N-terminal transmembrane domains
(TMDs) that mediate its insertion into the outer leaflet of the ER
membrane phospholipid bilayer, two TMD-flanking coiled coil
regions, and a C-terminal zinc-finger motif (ZFM) that is essential
for ER morphogenesis in yeast (Figure 3A). To map the KLHL12
bindingmotif in Lunapark, we generated multiple Lunapark dele-
tion mutants and tested their interaction with endogenous
KLHL12. We found that a proline-rich middle region (M, amino
acids 138–246) in Lunapark is required for its binding to
KLHL12 (Figure 3B). To narrow down the KLHL12 binding motif
in Lunapark, we aligned the M region in different Lunapark verte-
brate orthologs and identified three evolutionarily conserved re-
gions, which we termed M1, M2, and M3 (Figure 3A). A series of
pull-down experiments, in which the Lunapark DM1, DM2, and
DM3mutants were expressed in HEK293T cells and immunopre-
cipitated, narrowed the KLHL12 bindingmotif down to theM2 re-
gion of Lunapark (amino acids 202–210: SAPGGPPER) (Fig-
ure 3C). Accordingly, the KLHL12-mediated ubiquitylation of
the Lunapark DM2 mutant was decreased when compared to
the one of wild-type Lunapark (Figure 3D).
Further characterization of this 9-amino acid region by
alanine-scanning mutagenesis demonstrated that mutation of
the tri-amino-acid stretch SAP to AAA or GGP to AAA
completely abolished Lunapark binding to KLHL12 (Figure 3E).
Each of these tri-amino-acid stretches contains a proline form-
ing a PXXP core, which is known to mediate the interaction to
various domains that recognize proline-rich motifs (Kaneko
et al., 2008). Therefore, we mutated both proline residues (i.e.,
Pro204 and Pro207) to alanine and determined the ability of
the Lunapark(P204A/P207A) mutant to interact with KLHL12.
As shown in Figure 3F, mutations of Pro204 and Pro207
rendered Lunapark unable to interact with KLHL12. Accord-
ingly, Lunapark(P204A/P207A) is not ubiquitylated via KLHL12
in cultured cells (Figure 3G). Altogether, these data show that
a Lunapark proline-rich domain centered on Pro204 and
Pro207 mediates the binding of Lunapark to KLHL12 and its
ubiquitylation.
As an additional approach to characterize the Lunapark-
KLHL12 interaction, we employed immobilized synthetic pep-
tides comprising the KLHL12-binding domain of Lunapark (aa
200–213). A Lunapark peptide containing Pro204 and Pro207 in-
teracted with in vitro translated KLHL12, but not with a different
BTB-Kelch protein (KLHL18), whereas the same peptide inwhich
Pro204 andPro207were replaced by alanine did not associate atall, suggesting that Pro204 andPro207 directly mediate the bind-
ing to KLHL12 (Figure 3H).
These results were further supported by computational molec-
ular docking (Bordner and Abagyan, 2006; Lee et al., 2016;
Neves et al., 2012). The peptide comprising the KLHL12-binding
domain of Lunapark (aa 200–213) docks preferentially (large en-
ergy gap between lowest and next lowest conformation) to a
groove on the molecular surface of KLHL12 with Pro204 and
Pro207 forming the central loop of its interaction surface con-
tacting the Kelch repeats of KLHL12 and Arg210 stabilizing the
loop conformation intramolecularly (Figures 3I–3K). Replacing
Pro204 and Pro207 with Ala and re-docking resulted in displace-
ment of the peptide to a different, predicted conformation and
location on the complex (Figure 3L) and a large reduction in
the calculated energy of binding and the energy gap, indicating
a more transient interaction (Figure 3M).
Lunapark Ubiquitylation Does Not Regulate ER
Architecture and Dynamics
Next, we investigated the biological role of the KLHL12-depen-
dent ubiquitylation of Lunapark. Because Lunapark is involved
in the maintenance of the ER tubular network in mammalian cells
(Chen et al., 2015), we examined whether inhibition of Lunapark
ubiquitylation affects the architecture of the ER network and, in
particular, the relative abundance of its two main morphological
domains (i.e., ER sheets and tubules). To that end, we carried out
live cell imaging analysis in U2OS cells expressing moderate
levels of either GFP-tagged wild-type Lunapark or Luna-
park(P204A/P207A) as well as the ER marker Sec61b fused to
mCherry. As shown in Figures S3A and S3B, expression of the
ubiquitylation-resistant Lunaparkmutant did not affect the abun-
dance of ER sheets and tubules. To further investigate a possible
role of Lunapark ubiquitylation in the regulation of ER architec-
ture, we generated Lunapark knockout U2OS cells by
CRISPR-Cas9 genome editing. We then re-expressed in these
cells moderate levels of either GFP-tagged wild-type Lunapark
or Lunapark(P204A/P207A) (Figures S3C and S3D) as well as
the ER marker Sec61b (fused to mCherry). Cells expressing
GFP-tagged Lunapark(P204A/P207A) did not display any
detectable change in ER architecture when compared to cells
expressing wild-type Lunapark (Figures S3E and S3F). More-
over, both wild-type Lunapark and Lunapark(P204A/P207A)
were detected as puncta with a diameter of 0.5–1 mm at three-
way junctions (Figures S3 and S4) suggesting that the
KLHL12-dependent ubiquitylation of Lunapark is not required
for its localization to the ER three-way junctions. The same re-
sults were observed when the expression of KLHL12 was
silenced by RNAi (not shown). We then analyzed the mobility of
these junctions by marking the original position of Lunapark
puncta andmeasuring the time it takes for each Lunapark puncta
to move out of the circle. As shown in Figure S4, junctions with
Lunapark(P204A/P207A) were as stable as junctions with wild-
type Lunapark. Similarly, we did not observe differences in the
percentage of merging and splitting junctions between cells con-
taining Lunapark(P204A/P207A) and the ones containing wild-
type Lunapark (Figure S4). Finally, inhibition of the KLHL12-
dependent ubiquitylation of Lunapark does not affect Lunapark
ability to form oligomers (Figure S5).Cell Reports 31, 107664, May 19, 2020 5
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Figure 3. Identification of the KLHL12 Binding Site in Lunapark
(A) Top: schematic representation of WT Lunapark and the deletion mutants generated (TMD, transmembrane domain; CC, coiled-coil; ZFM, zinc-finger motif).
Bottom: alignment of the Lunapark M (middle) region in vertebrate species. The evolutionarily conserved regions M1, M2, andM3 are boxed in red. Point mutants
generated for alanine-scanning analysis are shown.
(B and C) HEK293T cells were transfected with an EV, HA-tagged WT Lunapark, or the indicated Lunapark mutants. WCEs were IP with anti-HA resin, and
immunocomplexes were probed with antibodies to the indicated proteins. In all immunoblot panels, white and black asterisks mark the HA-tagged proteins in the
IP and in the WCE.
(D) Ubiquitylation of Lunapark by KLHL12. HEK293T cells were transfected with HA-tagged Lunapark (WT or DM2 mutant), FLAG-tagged KLHL12, and MYC-
tagged ubiquitin. WCE were prepared in denaturing buffer and identical aliquots were immunoprecipitated with antibodies directed against MYC. Immuno-
precipitates were then immunoblotted to detect ubiquitylated Lunapark.
(E and F) As in (B) and (C).
(G) As in (D), except that the indicated Lunapark mutant was transfected instead of Lunapark DM2.
(H) In vitro binding between KLHL12 and a Lunapark peptide spanning Pro204 and Pro207. 35S-KLHL12 and KLHL18 were transcribed/translated in vitro and
incubated with beads coupled to a peptide spanning Pro204 and Pro207 or the same peptide in which Pro204 and Pro207 were replaced by alanine.
(I) Electrostatic surface rendering of KLHL12 with LunaparkWT peptide (black) with key residues highlighted: prolines whose substitution with alanines abrogates
binding (yellow); arginine forming intramolecular bridge (blue).
(J) Ribbon representation of the Kelch domain of crystallized KLHL12 (PDB: 2VPJ; blue, N terminus; red, C terminus) and the predicted binding conformation of
the Lunapark peptide.
(K and L) 90 anterior rotation of KLHL12 docking with Lunapark WT (K) or Lunapark(P204A/P207A) (L) peptide.
(M) Histogram of lowest energy conformation docking scores and energy gaps (Grigoryan et al., 2012) for Lunapark WT and the Lunapark(P204A/P207A) mutant
peptides.
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The mass spectrometry analysis of endogenous proteins that
copurified with FLAG-tagged Lunapark revealed the presence
of peptides of mechanistic target of rapamycin (mTOR) and
its cofactor mLST8 (Figure 4A). We confirmed the binding of
ectopically expressed Lunapark to endogenous mTOR and6 Cell Reports 31, 107664, May 19, 2020mLST8 by coimmunoprecipitation (Figure 4B). A complex
with endogenous Lunapark and mTOR was also detected by
either immunoprecipitating Lunapark (Figure 4C) or mTOR (Fig-
ure 4D). However, neither Raptor nor Rictor, complex-specific
subunits of mTORC1 and mTORC2 respectively, were detected
by immunoblotting or mass spectrometry in the Lunapark
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Figure 4. Lunapark Binds mTORC1 at ER Three-Way Junctions
(A) FLAG-tagged Lunapark was expressed in HEK293T cells and immunoprecipitated. Immunocomplexes were then analyzed by mass spectrometry. The
number of unique peptides identified by mass spectrometry in Lunapark and control immunopurifications is shown.
(B) HEK293T cells were transfected with an EV or HA-tagged Lunapark. WCEs were IP with anti-HA resin, and immunocomplexes were probed with antibodies to
the indicated proteins. In all immunoblot panels, white and black asterisks mark the HA-tagged proteins in the IP and in the WCE.
(C) WCE from HEK293T cells were immunoprecipitated with an anti-Lunapark antibody. Lunapark immunocomplexes were then probed with antibodies to the
indicated proteins. The red asterisk marks unspecific bands.
(D) WCE from parental or LNPK/ U2OS cells were immunoprecipitated with an anti-mTOR antibody. mTOR immunocomplexes were then probed with anti-
bodies to the indicated proteins. The red asterisks mark unspecific bands.
(legend continued on next page)
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mass spectrometry [AP-MS] shown in Figure 4A) and Triton
X-100 (used in the pull-down shown in Figures 4B–4D) are known
to disrupt the Raptor-mTOR andRictor-mTOR interactions (Hara
et al., 2002; Kim et al., 2002; Sarbassov et al., 2004), we immu-
noprecipitated Lunapark in the presence of the reversible cross-
linker dithiobis(succinimidyl propionate) (DSP) which was shown
to preserve both the Raptor-mTOR and Rictor-mTOR interac-
tions (Hara et al., 2002; Kim et al., 2002; Sarbassov et al.,
2004). Using these experimental conditions, we found that
Raptor is also part of the Lunapark-mTOR-mLST8 complex
that was pulled down from cell lysates (Figure 4E).
Next, we examined the ability of various Lunapark mutants to
coimmunoprecipitate with endogenous mTOR and mLST8. Two
Lunapark mutants that are still localized to the ER but do not
concentrate at the ER three-way junctions due to the deletion
of either of the two coiled-coil regions (CC1 or CC2) adjacent
to the transmembrane motifs (Figure 3A) (Wang et al., 2016;
Zhao et al., 2016) do not interact with mTOR and mLST8 (Fig-
ure 4F and 4G). Similarly, a Lunapark mutant that lacks the N-ter-
minal myristoylated Gly2, and consequently is not localized to
the ER, is unable to coimmunoprecipitate with mTOR and
mLST8 (Figures 3A, 4F, and 4G). Taken together, these results
indicate that the localization of Lunapark to ER three-way junc-
tions is required for its binding to mTORC1.
mTORC1-Positive Lysosomes and Late Endosomes
Form Contact Sites with Lunapark-Containing Three-
Way Junctions
We then characterized the Lunapark-mTOR interaction in
cultured cells. First, we detected, by in situ proximity ligation
assay (PLA), the interaction between endogenousmTORand Lu-
napark stably re-expressed (at physiological levels) in LNPK/
U2OS cells generated by CRISPR-Cas9 technology (Figures
5A–5C and S3C). No signal was observed when only one anti-
body was used in these cells or when both antibodies were
used in LNPK/ U2OS cells. Notably, in situ PLA carried out
in cells expressing GFP-Sec61b showed PLA puncta (marking
the mTOR/Lunapark interaction) at ER three-way junctions (Fig-
ure 5D). Second, we examined the localization of Raptor, the
complex-specific subunit of mTORC1, and Lunapark by live
confocal fluorescence microscopy. U2OS cells were transfected
with mCherry-Raptor and GFP-Lunapark and imaged by live
confocal fluorescence microscopy. As shown in Figure 5E,
Raptor-positive puncta were detected adjacent to Lunapark-
positive puncta at the cell periphery where both signals can be
well resolved.
The recruitment of mTORC1 to the membrane of lysosomes
and late endosomes (LyLEs) via the Rag guanosine triphospha-
tases (GTPases) in response to amino acids is an obligate step
in the activation of mTORC1 (Saxton and Sabatini, 2017). Once
at the LyLE surface, mTORC1 interacts with GTP-bound Rheb,
which unlocks the kinase activity of mTORC1 triggering phos-(E) As in (B) except that the reversible crosslinker dithiobis(succinimidyl propiona
(F) As in (B) except that the indicated Lunapark mutants (described in Figure 3A)
(G) U2OS cells expressing HA-taggedWT Lunapark or the indicated Lunapark mu
calreticulin (red). Scale bar indicates 5 mm.
8 Cell Reports 31, 107664, May 19, 2020phorylation of its substrates. Because active mTORC1 is local-
ized to the LyLE membrane, we tested whether ER three-way
junctions (where Lunapark resides) and LyLEs (where mTORC1
is recruited and activated) make contact. To visualize the ER
and LyLEs, U2OS cells were co-transfected with mCherry-
Sec61b (an ER marker) and GFP-LAMP1 (a LyLE marker). ER
and LyLEs were then imaged by live confocal fluorescence mi-
croscopy at the cell periphery where both organelles can be
well resolved (Figure 5F). LyLEs were found to be in close prox-
imity to, or in contact with, tubular regions of the ER and asso-
ciated with ER three-way junctions. This association was dy-
namic and variable as LyLEs transiently made contact and
overlap with ER three-way junctions and tubules before disso-
ciating and contacting the ER elsewhere. Examples of LyLE-ER
contacts are shown in Figure 5F. We could distinguish between
LAMP1-positive structures that overlap with ER three-way junc-
tions (top), are in apposition with three-way junctions (middle),
or partly overlap (bottom). Accordingly, when we imaged cells
expressing mCherry-LAMP1 and GFP-Lunapark, we observed
Lunapark-positive puncta contacting LAMP1-positive struc-
tures (Figures 5G and 5H). Finally, live cell imaging analysis of
triple-labeled U2OS cells expressing GFP-Lunapark, BFP-
KDEL (ER marker), and mCherry-LAMP1 (lysosome marker)
confirmed that Lunapark-positive ER three-way junctions and
LyLEs make contact (Figure S6). Of note, we observed LyLEs
associating with ER regions that contain Lunapark (mostly
at the ER three-way junctions) as well as LyLEs associating
with ER regions that do not contain Lunapark (not at ER
three-way junctions) in agreement with previous studies (Row-
land et al., 2014).
Inhibition of Lunapark Ubiquitylation Affects Lysosomal
Recruitment of mTORC1
Next, we assessed whether the KLHL12-dependent ubiquityla-
tion of Lunapark affects mTORC1 translocation to the lysosomal
membrane. We employed Lunapark-knockout U2OS cells
(generated by CRISPR-Cas9 technology) transduced with lenti-
viruses expressing physiological levels of either HA-tagged wild-
type Lunapark or the Lunapark(P204A/P207A) mutant that is un-
able to interact with KLHL12 and be ubiquitylated (Figures 6A
and S3D). These cells were stimulated with amino acids and
immunostained for endogenousmTORand the lysosomemarker
LAMP2 (Sancak et al., 2010). In cells expressing wild-type Luna-
park, mTOR colocalized with LAMP2 in the presence, but not in
the absence of amino acids where mTOR was dispersed
throughout the cytoplasm (Figure 6B-C). Cells expressing Luna-
park(P204A/P207A) displayed increased amino acid-induced
colocalization of mTOR with the lysosomal surface (LAMP2)
when compared with control cells.
As the translocation of mTORC1 to the lysosomal membrane
triggers its activation, we analyzed whether the KLHL12-medi-
ated ubiquitylation of Lunapark affects mTORC1 signaling activ-
ity. Compared to nutrient-stimulated cells expressing wild-typete) (DSP) was used.
were also expressed.
tants (as in E) were fixed and immunostained for HA (green) and the ERmarker
A B D
C
E F
G
H
Figure 5. mTORC1-Positive LyLEs Form Contact Sites with Lunapark-Containing Three-Way Junctions
(A) Parental, LNPK/, or LNPK/ U2OS cells re-expressing HA-tagged WT Lunapark were lysed. Whole cell extracts were analyzed by immunoblotting with
antibodies specific for the indicated proteins.
(B) In situ PLA of LNPK/ U2OS cells or LNPK/ U2OS cells re-expressing HA-tagged Lunapark probed with the indicated antibodies. Cells were counter-
stained with an anti-a-tubulin-FITC-conjugated antibody. The cell genotypes and the antibodies utilized are indicated on top. Scale bar indicates 10 mm.
(C) Quantification of (B). p values <0.0001 are indicated with four asterisks.
(D) As in (B), except that cells were transfected with GFP-Sec61b to visualize the ER network and not counterstained. Left andmiddle panels show two LNPK/ +
Lunapark-HA cells with PLA puncta localized to three-way junctions (pointed by white triangles, both anti-mTOR and anti-HA antibodies are employed). The right
panels show a LNPK/ cell stained with both antibodies (anti-mTOR and anti-HA). Scale bar indicates 2 mm.
(E) Live cell epifluorescence images and relative magnification insets of U2OS cells expressing mCherry-Raptor and GFP-Lunapark. Scale bar indicates 10 mm.
Corresponding line-scan graphs of the relative fluorescence intensities of GFP and mCherry along the line indicated in the images are shown (bottom). The top
line-scan graph corresponds to the left dotted line whereas the bottom line-scan graph corresponds to the right dotted line.
(F) As in (E), except that U2OS cells express mCherry-Sec61b and GFP-LAMP1. LAMP1 positive structures that overlap with ER three-way junctions (top), are in
apposition with three-way junctions (middle) or partly overlap (bottom) are shown.
(G) As in (E), except that U2OS cells express mCherry-LAMP1 and GFP-Lunapark.
(H) Percentage of mCherry-LAMP1 puncta that show overlap, association/proximity, or no association with GFP-Lunapark (n = 438).
See also Figures S3 and S6
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OPEN ACCESSLunapark, nutrient-stimulated cells expressing Lunapark(P204A/
P207A) displayed increased degree and duration of mTORC1
activation as measured by phosphorylation of the mTORC1 sub-
strate S6-kinase (Figures 6D and 6E). Of note, the pattern of S6K
phosphorylation looks alike in parental U2OS cells and LNPK/
U2OS cells reexpressing wild-type Lunapark indicating that theincreased mTORC1 activity observed in LNPK/U2OS cells re-
expressing Lunapark(P204A/P207A) is not due to its overexpres-
sion. To rule out that the observed phenotypemay result from the
expression of a non-functional Lunapark protein caused by the
Pro204/207 substitution that could impair protein structure and
function, we prevented Lunapark ubiquitylation in U2OS cellsCell Reports 31, 107664, May 19, 2020 9
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Figure 6. KLHL12-Dependent Ubiquitylation of Lunapark Limits mTOR Targeting to the Lysosomes and mTORC1 Activation
(A) Parental, LNPK/, or LNPK/U2OS cells re-expressingWT Lunapark or Lunapark(P204A/P207A) were lysed.WCEswere then analyzed by immunoblotting.
(B) LNPK/ or LNPK/ U2OS cells re-expressing (by lentiviral transduction) either WT Lunapark or Lunapark(P204A/P207A) were starved of amino acids for
50min and then re-stimulated for 10min. Cells were then fixed and immunostained for endogenousmTOR (green) and the lysosomal marker protein LAMP2 (red).
Colocalization panels show overlapping LAMP2 and mTOR signals. Scale bar indicates 10 mm.
(C) Quantification of mTOR/LAMP2 colocalization shown in (B). Three independent experiments were performed (n = 100 for each condition). Mean ± SD.
*p% 0.01.
(D) LNPK/ cells re-expressing WT Lunapark or Lunapark(P204A/P207A) were starved of amino acids for 50 min and then re-stimulated for the indicated times.
Cells were collected, lysed, and analyzed by immunoblotting.
(E) As in (D), except that also parental U2OS cells were also analyzed.
(F) U2OS cells were transfected with either an siRNA targeting KLHL12 or a control siRNA and then treated as in (D). The red asterisk marks an unspecific band.
(G) HEK293T cells were transfected with an EV or N11-CUL3-N199 and lysed. WCE were used for Lunapark immunoprecipitation (employing an anti-Lunapark
antibody) and analyzed by immunoblotting. As additional negative control, cells transfectedwith an EVweremocked immunoprecipitated using control IgGs. The
red asterisk marks an unspecific band.
See also Figures S3, S4, S5, S6, and S7.
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OPEN ACCESSby silencing KLHL12 expression. The phosphorylation of S6-ki-
nase was increased in KLHL12 knockdown cells when
compared with the one in cells transfected with control small
interfering RNA (siRNA) (Figure 6F) indicating that mTORC1 hy-
peractivation results from inhibition of the KLHL12-dependent
ubiquitylation of Lunapark. Moreover, the KLHL12-mediated
ubiquitylation of Lunapark limits mTORC1 activation also in
non-transformed cells. Indeed, as shown in Figures S7A and
S7B, the knockdown of KLHL12 as well as the expression of
the ubiquitylation-resistant Lunapark mutant in hTERT-RPE cells
results in increased degree and duration of mTORC1 activation.
We then tested the effect of blocking Lunapark ubiquitylation
in response to amino acid deprivation. The rationale behind
this experiment was to examine whether cells in which the10 Cell Reports 31, 107664, May 19, 2020KLHL12-mediated ubiquitylation of Lunapark is blocked are
insensitive to stimuli or conditions that inactivate mTORC1. As
shown in Figures S7C and S7D, cells expressing Luna-
park(P204A/P207A) display the same kinetics of mTOR inactiva-
tion when compared to cells expressing wild-type Lunapark as
judged by S6K dephosphorylation in response to nutrient with-
drawal. The same results were obtained when we blocked the
activity of mTORC1by treating cells with rapamycin (Figure S7E).
Inhibition of Lunapark Ubiquitylation Results in
Neurodevelopmental Defects
To investigate the role of the KLHL12-dependent ubiquitylation
of Lunapark in normal growth and development, one-cell stage
zebrafish embryos were microinjected with mRNA encoding
AB C D
Figure 7. Expression of the Ubiquitylation-
Resistant Lunapark Mutant in Zebrafish Re-
sults in Megalencephaly and Sensitizes Ze-
brafish to Pentylenetetrazole (PTZ) Treatment
(A) Dorsal view of a 2 dpf Tg(Elavl3:GCaMP6) embryo
employed for the phenotypic analysis described
in (B).
(B) Tg(Elavl3:GCaMP6) zebrafish embryos were in-
jected with mRNA encoding WT Lunapark or Luna-
park(P204A/P207A). The brain size of 2 dpf micro-
injected embryos was measured and normalized
against the body length. Mean ± SEM. ****p < 0.0001
(Student’s t test).
(C and D) Zebrafish embryos were injected as in (B).
Four dpf injected larvae were placed in wells of a flat-
bottom plate. Locomotion analysis was carried out
as described in the STARMethods. The graphs show
velocity (C) and distance covered (D) by the injected
larvae. Mean ± SEM. *p < 0.05, **p < 0.01 (Student’s
t test).
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OPEN ACCESSwild-type Lunapark or Lunapark(P204A/P207A). No significant
phenotypic alterations in the head, heart, swim bladder, eye,
tail, and fin were identified in injected zebrafish until 5 days
post-fertilization (dpf). However, larvae expressing Luna-
park(P204A/P207A) displayed larger brains when compared to
sibling larvae expressing wild-type Lunapark (Figures 7A and
7B). Interestingly, mTOR signaling has been shown to be critical
in brain development. Loss of function mutations in the tuberous
sclerosis complex TSC1 or TSC2 genes, which lead to dysregu-
lated mTOR activity, are associated with brain lesions, epilepsy,
cognitive impairment, and autism (Luarte et al., 2018; Switon
et al., 2017). Moreover, mTOR hyperactivation resulting from in-
hibition of TSC2 or Depdc5 expression in zebrafish has been
associated with altered locomotion activity (de Calbiac et al.,
2018; Scheldeman et al., 2017). Therefore, we tested whether
blocking Lunapark ubiquitylation affects locomotion activity in
zebrafish. Four dpf larvae injectedwithwild-type Lunapark or Lu-
napark(P204A/P207A) mRNAs were placed into individual wells
of a 24-well plate and acclimated to a recording chamber. Loco-
motor analysis performed in basal condition did not revealed sig-
nificant differences in activity between the two samples (data not
shown). However, Lunapark(P204A/P207A)-expressing larvae
treatedwith low doses of theCNS proconvulsant pentylenetetra-
zole (PTZ) displayed increased locomotor activity when
compared to larvae injected with wild-type Lunapark (Figures
7C and 7D). Taken together, our results show that inhibition of
Lunapark ubiquitylation in zebrafish results in megalencephaly
and increased sensitivity to chemical compounds that induce
epilepsy.
DISCUSSION
Our biochemical data indicate that the interaction of Lunapark
with KLHL12 is mediated by the Kelch repeats of KLHL12 anda Lunapark proline-rich domain centered on Pro204 and
Pro207. These results are supported by computational molecu-
lar docking, which indicates that the peptide containing Pro204
and Pro207 is also structurally and energetically complementary
to the KLHL12 binding groove and is displaced by mutation of
the prolines. Currently we do not know how the KLHL12-Luna-
park interaction is regulated, however, we believe that proline
hydroxylation might control Lunapark binding to KLHL12.
Indeed, we retrieved Lunapark peptides harboring hydroxylated
Pro204 in our mass spectrometry data and found that Pro204,
which is essential for Lunapark binding to KLHL12, lies within a
region matching the canonical X-Pro-Gly recognition sequence
of prolyl 4-hydroxylases (P4Hs), enzymes that catalyze proline
hydroxylation, yielding (2S,4R)-4-hydroxyproline (Hyp) (Gorres
and Raines, 2010; Qi et al., 2008). P4Hs are a2b2 tetramers in
which the a-subunits contain enzymatic activity and a sub-
strate-binding domain, while the b-subunits function as a protein
disulfide isomerase (PDI) that anchors the enzyme to the ER. For
the prolyl hydroxylation reaction P4Hs require a-ketoglutarate
(aKG), which acts as the rate limiting electron donor under nor-
moxic conditions (Gorres and Raines, 2010; Qi et al., 2008).
aKG is the product of the deamination of glutamine, a potent
mTORC1 activator. Indeed during glutaminolysis, glutaminases
catalyze the conversion of glutamine into glutamate, which is
then deamined to aKG (Dura´n et al., 2013; Jewell et al., 2015; Vil-
lar et al., 2015). The conversion of glutamate to aKG depends on
the allosteric activation of glutamate dehydrogenase (GDH) by
leucine and the metabolism of other amino acids, such as argi-
nine, proline, and histidine, also results in aKG production.
Thus, the KLHL12-mediated ubiquitylation of Lunapark might
be part of a feedback mechanism in which amino acid abun-
dance increases aKG production thus promoting the P4H-
dependent hydroxylation of Lunapark. In turn, hydroxylation of
Pro204 would stimulate Lunapark interaction with KLHL12 andCell Reports 31, 107664, May 19, 2020 11
Article
ll
OPEN ACCESSLunapark ubiquitylation, preventing nutrient-stimulated hyper-
accumulation of mTORC1 on the lysosomal membrane and de-
regulated mTORC1 signaling.
How the KLHL12-dependent ubiquitylation of Lunapark limits
the activation of mTORC1 in response to amino acids is not
known. Our results show that inhibition of Lunapark ubiquityla-
tion decreases its interaction with mTOR (Figure 6G). Interest-
ingly, it has been recently shown that when amino acids are
abundant, mTORC1 is only transiently associated with the lyso-
somal membrane as it undergoes dynamic binding and release
cycles at the lysosomal surface (Lawrence et al., 2018). This
mechanism prevents mTORC1 hyperactivation by reducing the
amount of time during which mTORC1 is in direct contact with
its activator Rheb at the lysosomal membrane. One possibility
that needs to be tested is that Lunapark ubiquitylation mediated
by KLHL12 could regulate the accumulation of mTORC1 to the
lysosomal membrane by affecting its spatial cycling.
Our data demonstrate that inhibition of Lunapark ubiquityla-
tion results in neurodevelopmental defects in D. rerio. Although
Lunapark is ubiquitously expressed, it is present at high levels
in the CNS of mice and chickens during embryo development
and is involved in synaptic vesicle transport in C. elegans
neuronal structures (Ghila and Gomez, 2008). Furthermore, Lu-
napark expression was observed throughout brain development
in both mice and humans as well as in differentiating neural pre-
cursor cells (Breuss et al., 2018). Recently, homozygous muta-
tions in the gene encoding Lunapark have been described in
three children with a recessive neurodevelopmental syndrome
characterized by intellectual disability, psychomotor develop-
mental delay, defects in social interactions, hyperactivity, inat-
tention, and epilepsy (Breuss et al., 2018). Interestingly, hyperac-
tivation of mTORC1 signaling observed in tuberous sclerosis
complex patients results in epilepsy, neurodevelopmental de-
lays, behavioral problems including attention deficit hyperactiv-
ity disorder, and autism spectrum disorder (Luarte et al., 2018;
Switon et al., 2017).Moreover, mutations in any of the three com-
ponents (DEPDC5, NPRL2, and NPRL3) of the GATOR1 com-
plex, which inhibits mTORC1 signaling by acting as a GAP for
RagA/B, results in epilepsy (Marsan and Baulac, 2018).
Although proper ER morphology is key in many cellular pro-
cesses and tissues, axons that require a highly elongated ER
polygonal network are more sensitive to perturbations of the
ER architecture (Luarte et al., 2018). Indeed, the axonal ER
network is essential for vesicular transport from the soma to
the axon growth cone, lipid, and cholesterol synthesis as well
as their trafficking to the synapses, and it is crucial for axonal
Ca2+ dynamics. Accordingly, mTOR has been shown to be
essential for neuron development, specifically dendritogenesis,
neuronal physiology, axon guidance, and axonogenesis. An
assessment of the role of Lunapark ubiquitylation in neurons
and its potential implication in neurodegeneration should be
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Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Daniele
Guardavaccaro. (daniele.guardavaccaro@univr.it).
Materials Availability
All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agree-
ment. Commercially available reagents are indicated in the Key Resources Table.
Data and Code Availability
This article includes all datasets/code generated or analyzed during this study (Tables S1 and S2).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human cells, transfection and drug treatment
HEK293T, HeLa, U2OS and hTERT-RPE cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Thermo Fisher Sci-
entific) containing 10% fetal calf serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. Cells were transfected by the polyethyle-
nimine (PEI) method. siRNA oligonucleotide against human KLHL12 was purchased from Dharmacon (Clone ID: 2958852) and trans-
fected into cells using Lipofectamine RNAiMAX (Thermo Fisher Scientific) according to manufacturer’s protocol. The following drugs
were used: MG132 (Peptide Institute, 10 mM), MLN4924 (Active Biochemicals, 0.5 mM), and cycloheximide (Sigma-Aldrich, 100 mM).
Zebrafish embryo injections and analysis
Wild-type and transgenic [Tg(Elavl3:GCaMP6)] zebrafish lines were maintained under standard husbandry conditions andmated ac-
cording to standard procedures at the Interdepartmental Centre for Experimental Research (CIRSAL) of the University of Verona.
mRNAs for injection were transcribed using the mMESSAGE mMACHINE SP6 Transcription Kit (ThermoFisher Scientific-Ambion)
using linearized pCS2+ constructs as template. One-cell stage zebrafish embryos were injected with 2.5 pg of mRNA [wild-type Lu-
napark or Lunapark(P204A/P207A)] as previously described (Astone et al., 2018). Injected fish were screened to detect the presence
of phenotypic alterations including evident morphological distortion, cardiac edema, abnormalities of head, eye, tail and fin by visual
assessment.
For brain analysis, the Tg(Elavl3:GCaMP6) transgenic reporter line, which displays robust transgene expression in the brain at 2
dpf, was employed (Turrini et al., 2017). Two dpf injected embryos were positioned dorsally in 3% methylcellulose on a microscope
slide. Images were taken using a LEICA MZ16F fluorescence microscope and the Leica Application Suite V4.12 software. The brain
size was measured using the Fiji-ImageJ software and normalized against the body length. GraphPad Prism was used to conduct
statistical analysis (Student’s t test). For locomotion analysis, 4 dpf injected larvae were placed individually in wells of a 24-well
flat-bottomed culture dish. Locomotion was tracked for 30 minutes in basal condition followed by 45 minutes of recording after
administration of 1.25 mM pentylenetetrazole (PTZ) at 28.5C using a DanioVision system (Noldus) consisting of an isolated chamber
with an infrared camera. Both the distance traveled and the velocity of swimming were analyzed using the EthoVision XT-15 loco-
motion tracking software. GraphPad Prismwas used for statistical analysis (Student’s t test). Differences were considered significant
if p < 0.05. All experiments were carried in accordance to the Italian law on animal experimentation (D.L. 4 March 2014, n.26), under
authorization n186474 (27/05/2019).e2 Cell Reports 31, 107664, May 19, 2020
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Plasmids, cloning and lentivirus production
The Cullin-3 deletion mutants CUL3-N199 and CUL3-N225 carrying one or two C-terminal FLAG tags, respectively, were generated
by PCR and subcloned into the pcDNA3 vector. The membrane-targeted Cullin-3 mutants (CUL3-N199-MB and CUL3-N225-MB)
were constructed by fusing the first 11 amino acids of DCNL3 (Meyer-Schaller et al., 2009) to the N-terminal of the CUL3 deletion
mutants by PCR. Human Lunapark and KLHL12 cDNAs were obtained from GE Healthcare. Lunapark carrying C-terminal
2xFLAG-2xHA or a single HA and KLHL12 carrying an N-terminal FLAG were subcloned into pcDNA3. Deletion mutants of Lunapark
(DMs, DZFM, DC) and KLHL12 (DKelch1-3, DKelch4-6) were generated by PCR and subcloned into pcDNA3. The HA-tagged Luna-
park(P204A/P207A) was generated by site-directed mutagenesis (Stratagene). Lunapark WT, DM2 and P204A/P207A were also
subcloned into pEGFP-N1. mCherry-Sec61b (Addgene plasmids # 49155) and Rtn4a-GFP (Addgene plasmids # 61807) were gifts
from Gia Voeltz, LAMP1-GFP (Addgene plasmids # 34831) was a gift from Esteban Dell’Angelica, LAMP1-mCherry (Addgene plas-
mids # 45147) was a gift from Amy Palmer, pAc-GFPC1-Sec61b (Addgene plasmids # 15108) was a gift from Tom Rapoport, pRK5-
HA-mCherry-RAPTOR (Addgene plasmids # 73386) was a gift from Jie Chen and Taekjip Ha. For lentiviral transduction, wild-type
Lunapark and mutants were subcloned into pHAGE2-EF1a-IRES-puromycin vectors (Wilson et al., 2008). For lentiviral transduction,
HEK293T cells were transfected by the polyethylenimine (PEI) method with the pHAGE2 vector together with packaging vectors en-
coding Gag-Pol, Rev, Tat, and the G protein of the vesicular stomatitis virus (VSV). Supernatants were collected every 48 hours on
two consecutive days starting 24 hours after transfection, filtered and transferred to cells in the presence of polybrene (4 mg/ml).
Identification of CUL3 and Lunapark interactors
HEK293T cells were transfected with pcDNA3-FLAG-CUL3-N199, pcDNA3-2xFLAG-CUL3-N225, pcDNA3-FLAG-CUL3-N199-MB,
pcDNA3-2xFLAG-CUL3-N225-MB or pcDNA3-Lunapark-2xFLAG-2xHA. Cells were harvested and subsequently lysed in lysis buffer
[50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, and 0.5% NP-40 plus protease and phosphatase inhibitors]. CUL3 and Luna-
park were immunopurified with anti-FLAG agarose resin (Sigma-Aldrich). The beads were washed and proteins were eluted using
RapiGest SF (Waters). Eluents were subsequently treated with reduction buffer (1 mg/ml dithiothreitol) for 30 minutes and alkylation
buffer (5 mg/ml iodoacetamide) for 20minutes, followed by Lys-C for 4 hours. Trypsin was then added at the 1:50 ratio andmixturewas
incubated overnight at 37C. Trypsin was quenched by adding trifluoroacetic acid (TFA). Themixturewas then subjected toC18SEP-
PAK desalting.
For MS analysis, peptides were first separated with a C18 column (Zorbax) and introduced by nanoelectrospray into the LTQOrbi-
trap Elite (Thermo Fisher) and MS/MS in data-dependent decision tree mode (collision-induced dissociation/electron transfer disso-
ciation) as described previously (Low et al., 2014). Raw files were converted to MGF files using Proteome Discoverer version 1.4
(Thermo Fisher). The non-fragment filter was used to simplify ETD spectra and the Top N filter (6 highest peaks admitted per 100
Da) for the CID spectra. All MGF files were submitted to Mascot search engine (version 3.0) via Proteome Discoverer version 1.4.
The spectra were searched against the UniProt Human database (version 2013-07, 20,277 entries). Trypsin/P was chosen as the pro-
tease with 2 missed cleavages, cysteine carbamidomethylation was set as fixed modification; and oxidation of methionine and acet-
ylation of the N terminus of the protein were set as variable modifications. Peptide tolerance was set to 15 ppm andMS/MS tolerance
set to 0.5 dalton. All peptide-spectrum matches (PSMs) were filtered at a Mascot score cutoff at 30. Only PSMs with a minimum
length of 7 amino acids were kept. To normalize spectral count data, we exported the full list with Normalized Spectral Abundance
Factors (NSAF). NSAF is calculated as the number of spectral counts (SpC) identifying a protein, divided by the protein’s length (L), in
turn divided by the sum of SpC/L for all proteins in the experiment.
CRISPR genome editing
To generate LNPK/ cell lines, two optimal gRNA target sequences targeting both exon 1 and exon 13 (genomic deletion) were de-
signed using the Benchling CRISPR Genome Engineering tool and cloned into pSpCas9(BB)-2A-GFP (PX458). U2OS cells were
seeded into 10-cm dishes at approximately 70% confluency and transfected with 2.5 mg of both gRNA-containing PX458 plasmids
using the polyethylenimine (PEI) method. Two days after transfection, GFP-positive cells were sorted using the BD FACSJazzTM cell
sorter, and 20 cells/well were plated in a 96-well plate. One to two weeks later, single cell clones were picked, trypsinized in 0.25%
Trypsin-EDTA for 5 minutes, and plated into individual wells of a 96-well plate for genotyping. Genomic DNAwas collected usingDNA
lysis buffer (100 mM Tris-HCl pH 8.0, 200 mM NaCl, 5 mM EDTA pH 8.0, 0.2% SDS) supplemented with 10 mg/ml proteinase K.
Genotyping PCRs were performed with GoTaq G2 Flexi DNA Polymerase (Promega), using primers surrounding the genomic target
sites. Positive clones were sequenced to determine the presence of deletion event (LNPK knockout). To further validate the muta-
tional status of candidate clones, single clones were screened for Lunapark expression by immunoblotting.
Biochemical methods
For preparation of cell extracts, cells were washed and collected in ice-cold PBS and lysed in Triton-X lysis buffer (50 mMTris pH 7.5,
250mMNaCl, 0.1% Triton X-100, 1 mMEDTA, 50 mMNaF and protease and phosphatase inhibitors) for 30 minutes on ice, followed
by centrifugation for 20 minutes at 4C. Cell extracts were then submitted to either immunoblotting or immunoprecipitation followed
by immunoblotting. For immunoprecipitation, cell extracts were first precleared by incubation with protein G- or protein A-SepharoseCell Reports 31, 107664, May 19, 2020 e3
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OPEN ACCESSbeads (Thermo Fisher Scientific) for 45 minutes at 4C. Precleared extracts were incubated with the indicated antibody for 3 hours at
4C followed by protein G- or protein A-Sepharose beads for 45 minutes. Beads were washed 4 times with lysis buffer and proteins
were eluted in 5x Laemmli sample buffer [50mM Tris-HCl, pH 6,8, 2% (w/v) SDS, 5% (v/v), b-mercaptoethanol, 0,1% (w/v) bromo-
phenol blue and 1% (v/v) glycerol]. The immunoprecipitation in the presence of the crosslinking agent dithiobis (succinimidyl propio-
nate)(DSP) (Thermo Fisher Scientific PG82081) was performed as previously described (Kim et al., 2002). For immunoblotting,
proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto PVDF membranes (Merck-
Millipore), and incubated with the indicated antibodies. For ubiquitylation assay in cultured cells, HEK293T cells were transfected
with pcDNA3-Lunapark-HA (WT or mutants), pcDNA-FLAG-KLHL12 (WT or DKelch4-6), or pWC7-His-MYC-ubiquitin (WT or
K-less), as indicated. Forty-eight hours later, cells were treated with MG132 for 4 hours before harvesting. Cells were lysed in
RIPA buffer (25 mM Tris pH 7.5, 150 mM NaCl, 1% NP40, 1% sodium deoxycholate, 0.1% SDS and protease and phosphatase in-
hibitors) and subjected to immunoprecipitation using c-Myc antibody. Ubiquitylated Lunapark was detected by immunoblotting us-
ing an anti-Lunapark antibody.
Antibodies
The following antibodies were used in this study: anti-Lunapark, rabbit polyclonal (Sigma-Aldrich, HPA014205), anti-KLHL12, mouse
monoclonal (Cell Signaling Technology, 9406), anti-FLAG, rabbit polyclonal (Sigma-Aldrich, F7425), anti-FLAG, mouse monoclonal
(Sigma-Aldrich, F7425), anti-HA, mouse monoclonal (Biolegend, 901514), anti-HA, rabbit monoclonal (Cell Signaling Technology,
3724), anti-b-actin, mousemonoclonal (Santa Cruz, sc-69879), anti-Myc, mousemonoclonal (Sigma-Aldrich, M5546), anti-GFP, rab-
bit polyclonal (Torrey Pines Biolabs, TP401), anti-GbL(mLST8), rabbit monoclonal (Cell Signaling Technology, 3274), anti-AKT, rabbit
polyclonal (Bethyl Laboratories, A302-065A), anti-phospho-p70-S6K (Thr389), rabbit monoclonal (Cell Signaling Technology, 9234),
anti-p70-S6K, rabbit polyclonal (Bethyl Laboratories, A300-510A), anti-Raptor, rabbit polyclonal (Bethyl Laboratories, A300-553A),
anti-Rictor, rabbit monoclonal (Cell Signaling Technology, 2114), anti-Deptor/DEPDC6, rabbit monoclonal (Cell Signaling Technol-
ogy, 11816). Anti-mouse IgG (NA931) and anti-rabbit IgG (NA934) horseradish peroxidase (HRP) conjugated secondary antibodies
were from GE Healthcare. The following primary antibodies were used for immunofluorescence and proximity ligation assays: anti-
HA, mouse monoclonal (Biolegend, 901514), anti-mTOR, rabbit monoclonal (Cell Signaling Technology, 2983), anti-mTOR, mouse
monoclonal (Merck-Millipore, 05-1592), anti-LAMP2/CD107b, mousemonoclonal (Novus Biologicals, NBP2-22217SS) and anti-Cal-
reticulin, rabbit polyclonal (Abcam, ab2907). Alexa Fluor 488-, Alexa Fluor 568- or Alexa Fluor 594-conjugated secondary antibodies
were from Thermo Fisher Scientific.
Immunofluorescence
Cells were seeded on polylysine-L (Sigma-Aldrich) treated glass coverslips and, when specified, transfected with the indicated plas-
mids. One day after transfection, cells were fixedwith 4%paraformaldehyde (PFA), permeabilized with 0.1%Triton X-100 in PBS and
incubated with primary antibodies for 1.5 hours at room temperature. Cells were washed three times using 0.5% Tween-20 in PBS
(PBS-T) and incubated with Alexa Fluor 488-, Alexa Fluor 568- or Alexa Fluor 594-conjugated secondary antibodies (Thermo Fisher
Scientific) for 1 hour at room temperature. Cells were washed three times with PBS-T and slides were mounted using the Vectashield
antifade mounting medium (Vector Laboratories). Fluorescence images were acquired on a Leica DM6000 fluorescence microscope
and analyzed using the ImageJ (NIH) software. The colocalization plugin in ImageJ was used to visualize co-localization between two
channels (thresholds were set equal for all images analyzed).
In situ proximity ligation assay (PLA)
Cells were seeded on glass coverslips treated with polylysine-L (Sigma-Aldrich). After 24 hours, cells were fixed with 4%paraformal-
dehyde (PFA) and permeabilized with 0,1% Triton X-100 in PBS. The PLA assay was performed according to themanufacturer’s pro-
tocol (Duolink In situ Red, Sigma-Aldrich DUO92101-1KT). Briefly, following permeabilization, the coverslips were subjected to
blocking, incubation with primary antibodies for 1.5 hours at room temperature, hybridization with PLA probes, ligation, amplification
and counterstaining with mouse monoclonal anti-a-tubulin antibody-FITC (Sigma-Aldrich F2168) before mounting. Fluorescent
images were acquired on a Leica DM6000 fluorescence microscope and analyzed using the ImageJ software (NIH). The number
of PLA punctae, indicative of a direct interaction between Lunapark and mTOR, were counted for all three conditions (n < 20 cells).
P values were determined by unpaired, two-tailed Student’s t test using Graphpad Prism 7. P values < 0.05 are indicated with one
asterisk, < 0.01 with two asterisks, < 0.001 with three asterisks and < 0.0001 with four asterisks, respectively.
Live cell imaging by spinning disc confocal microscopy
U2OS cells were grown in glass bottom dishes and transfected with mCherry-Sec61b, Lunapark-GFP (WT or mutants), mCherry-
Raptor, mCherry-LAMP1 or GFP-LAMP1. One day after transfection, cells were imaged using a Nikon-SD spinning disk confocal
microscope. The movies were generated using the ImageJ software (NIH). The multichannel plot profile function in ImageJ was
used to obtain line-scan graphs representing the relative fluorescence intensity of the mCherry and GFP channels along the length
(linear distance in pixels) of a line drawn in ImageJ. For triple-labeled live cell imaging, U2OS cells were transfected with Lunapark-
GFP, BFP-KDEL (ER marker) and mCherry-LAMP1 (lysosome marker). One day after transfection, cells were imaged using a Leica
TCS SP5 AOBS (Acousto-Optical Beam Splitter) confocal microscope and analyzed using the ImageJ (NIH) software.e4 Cell Reports 31, 107664, May 19, 2020
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In vitro translated 35S-labeled KLHL12 or KLHL18 were incubated with protein G-Sepharose beads precoupled with the following
Lunapark synthetic peptides: H-DSSAPGGPPERTVT-OH, or H-DSSAAGGAPERTVT-OH for 2 hours at 4C. Beads were washed
four times with lysis buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 250 mM NaCl, 0.1% Triton X-100, 50 mM NaF, 1 mM DTT,
0.1 mM Na3VO4). Proteins were then eluted with Laemmli buffer for 3 minutes at 95
C and subjected to SDS-PAGE followed by
autoradiography.
Computational molecular docking of Lunapark peptide to KLHL12
A highly accurate, flexible peptide docking method (ICM-Pro, Molsoft LLC, La Jolla CA) was used as previously described (Bordner
and Abagyan, 2006; Lee et al., 2016) to dock Lunapark peptides to KLHL12. Full atom models of Lunapark peptides were docked to
grid potential maps generated from the atomic coordinates of the Kelch repeats of KLHL12 reported in the crystallographic structure
of KLHL12 (Canning et al., 2013). The all-atom model of the peptide was docked into the grid potentials using stochastic global
optimization in internal coordinates with pseudo-Brownian and collective ‘probability-biased’ random moves as implemented in
the ICM-Pro program. For the grids, five types of potentials for the peptide-receptor interaction energy - hydrogen van der Waals,
non-hydrogen van der Waals, hydrogen bonding, hydrophobicity and electrostatics - were precomputed on a rectilinear grid with
0.5 A˚ spacing that fills a 34 A˚ 3 34 A˚ 3 25 A˚ box containing KLHL12, to which the peptide was docked by searching its full confor-
mational space within the space of the grid potentials. The preferred docking conformation was identified by the lowest energy
conformation in the search.
QUANTIFICATION AND STATISTICAL ANALYSIS
GraphPad Prismwas used for statistical analysis (Student’s t test). Sample sizes and p values are indicated in STARMethods, figures
or figure legends. All images are representative of at least three biological replicates, except where specified in the figure legends.Cell Reports 31, 107664, May 19, 2020 e5
